Skip to content

Evaluation of near-infrared fluorescence (NIRF) imaging for detection of lymph nodes (LN) in cervical cancer: a feasibility study

Evaluation of near-infrared fluorescence (NIRF) imaging for detection of lymph nodes (LN) in cervical cancer: a feasibility study - LN detection in cervical cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33291
Enrollment
10
Registered
2009-05-18
Start date
2009-03-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer sentinel node procedure

Interventions

None listed

Sponsors

Gynaecologie & Obstetrie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: women > 21 years of age with biopsy proven cervical cancer who are scheduled to undergo hysterectomy with pelvic lymphadenectomy

Exclusion criteria

Exclusion criteria: Pregnant women, renal failure, cardiac or pulmonary diseases, allergy against iodine, previous anaphylactic or allergic reactions against insect bites or medication, hyperthyreoidism

Design outcomes

Primary

MeasureTime frame
To assess the detection and location of metastatic (sentinel) lymph nodes in patients with primary cervical cancer, by using a NIRF camera system.

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)